Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Net Cash Flow (2016 - 2020)

Historic Net Cash Flow for Forte Biosciences (FBRX) over the last 5 years, with Q4 2020 value amounting to $38.6 million.

  • Forte Biosciences' Net Cash Flow rose 530080.86% to $38.6 million in Q4 2020 from the same period last year, while for Dec 2020 it was $51.8 million, marking a year-over-year increase of 259505.98%. This contributed to the annual value of -$14.9 million for FY2024, which is 27436.48% down from last year.
  • Forte Biosciences' Net Cash Flow amounted to $38.6 million in Q4 2020, which was up 530080.86% from -$7.6 million recorded in Q3 2020.
  • Forte Biosciences' Net Cash Flow's 5-year high stood at $69.2 million during Q2 2017, with a 5-year trough of -$38.9 million in Q4 2017.
  • Over the past 5 years, Forte Biosciences' median Net Cash Flow value was -$826000.0 (recorded in 2016), while the average stood at $4.2 million.
  • The largest annual percentage gain for Forte Biosciences' Net Cash Flow in the last 5 years was 1448881.86% (2017), contrasted with its biggest fall of 417571.43% (2017).
  • Quarter analysis of 5 years shows Forte Biosciences' Net Cash Flow stood at -$910000.0 in 2016, then plummeted by 4175.71% to -$38.9 million in 2017, then surged by 144.54% to $17.3 million in 2018, then plummeted by 104.28% to -$742000.0 in 2019, then surged by 5300.81% to $38.6 million in 2020.
  • Its Net Cash Flow stands at $38.6 million for Q4 2020, versus -$7.6 million for Q3 2020 and $10.9 million for Q2 2020.